|
(E) |
1. |
Which one of the following has not been
suggested as response predictor of
intravesical BCG therapy for superficial
bladder cancer?(JTUA 18:1-11,2007) |
| |
|
A、TNF-alpha
B、proteinuria
C、IL-8
D、p53 nuclear overexpression
E、leukocytosis |
|
(C) |
2. |
Currently the first choice of
intravesical therapy for patients with
higher risks of superficial bladder
cancer after transurethral resection in
preventing tumor recurrence or treating
CIS and residual tumors is: (JTUA
18:1-11,2007) |
| |
|
A、mitomycin-C
B、thiotepa
C、BCG
D、adriamycin
E、gemcitabine |
|
(E) |
3. |
Where are muscarinic receptors found in
the urinary bladder? (JTUA
18:12-16,2007) |
| |
|
A、Detrusor muscle
B、Autonomic nerve endings
C、Sensory nerve endings
D、Urothelium
E、All of the above |
|
(A) |
4. |
The ultrasonographic presentation of
renal subcapsular hematoma is generally
(JTUA 18:31-32,2007) |
| |
|
A、hypoechoic
B、isoechoic
C、hyperechoic
D、mixed echogenicity |
|
(A) |
5. |
One of smooth muscle cell makers for
immunohistochemical diagnosis of renal
capsular leiomyoma is: (JTUA
18:33-35,2007) |
| |
|
A、actin
B、cytokeratin
C、PSA
D、CBF-35
E、CPI-25 |
